Common variants in β2- and β3-adrenergic receptor genes and uncoupling protein 1 as predictors of the risk for type 2 diabetes and body weight changes. The Finnish Diabetes Prevention Study [1]

Clinical Genetics

Volumn 66, Issue 4, 2004, Pages 365-367

  Salopuro, Titta ^a,b   Lindstrom J ^a   Eriksson, J G ^a   Valle, T T ^a   Hamalainen H ^a   Ilanne Parikka, P ^a   Keinanen Kiukaanniemi S ^a   Tuomilehto, J ^a   Laakso, M ^a   Uusitupa, M ^a  

^a Finnish Diabet Prev Study Group   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; DNA; GLUCOSE; GLUTAMINE; GLYCINE; INSULIN; TRYPTOPHAN; UNCOUPLING PROTEIN 1; CARRIER PROTEIN; ION CHANNEL; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN;

ADULT; ANAMNESIS; ANTHROPOMETRY; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FINLAND; FOLLOW UP; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; LETTER; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; GENETICS; MITOCHONDRION; PREDICTION AND FORECASTING; RISK FACTOR; WEIGHT GAIN;

CARRIER PROTEINS; DIABETES MELLITUS, TYPE 2; FINLAND; HUMANS; ION CHANNELS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; RISK FACTORS; VARIATION (GENETICS); WEIGHT GAIN;

EID: 4844229786     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2004.00313.x     Document Type: Letter

References (22)

1. Kahn CR, Vicent D, Doria A. Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu Rev Med 1996: 47: 509-531.
2. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Annu Rev Med 2003: 54: 453-471.
3. Arner P. Genetic variance and lipolysis regulation: implications for obesity. Ann Med 2001: 33 (8): 542-546.
4. Dalgaard LT, Pedersen O. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia 2001: 44 (8): 946-965.
5. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994: 33 (32): 9414-9419.
6. Large V, Hellström L, Reynisdottir S et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997: 100 (12): 3005-3013.
7. Ehrenborg E, Skogsberg J, Ruotolo G et al. The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. J Intern Med 2000: 247 (6): 651-656.
8. Iwamoto N, Ogawa Y, Kajihara S et al. Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver. Clin Chim Acta 2001: 314 (1-2): 85-91.
9. Rosmond R, Ukkola O, Chagnon M, Bouchard C, Björntorp P. Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med 2000: 248 (3): 239-244.
10. Carlsson M, Orho-Melander M, Hedenbro J, Groop LC. Common variants in the beta2-(Gln27Glu) and beta3-(Trp64Arg) - adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes. Diabetologia 2001: 44 (5): 629-636.
11. Walston J, Silver K, Bogardus C et al. Time of onset of noninsulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995: 333 (6): 343-347.
12. Clément K, Vaisse C, Manning BS et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995: 333 (6): 352-354.
13. Widén E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995: 333 (6): 348-351.
14. Hoffstedt J, Poirier O, Thorne A et al. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 1999: 48 (1): 203-205.
15. Heilbronn LK, Kind KL, Pancewicz E, Morris AM, Noakes M, Clifton PM. Association of -3826 G variant in uncoupling protein-1 with increased BMI in overweight Australian women. Diabetologia 2000: 43 (2): 242-244.
16. Sivenius K, Valve R, Lindi V, Niskanen L, Laakso M, Uusitupa M. Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on longterm body weight change in Finnish type 2 diabetic and non-diabetic control subjects. Int J Obes Relat Metab Disord 2000: 24 (4): 514-519.
17. Fogelholm M, Valve R, Kukkonen-Harjula K et al. Additive effects of the mutations in the beta3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women. J Clin Endocrinol Metab 1998: 83 (12): 4246-4250.
18. Tuomilehto J, Lindström J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001: 344 (18): 1343-1350.
19. Eriksson J, Lindström J, Valle T et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999: 42 (7): 793-801.
20. Walston J, Silver K, Hilfiker H et al. Insulin response to glucose is lower in individuals homozygous for the Arg 64 variant of the beta-3-adrenergic receptor. J Clin Endocrinol Metab 2000: 85 (11): 4019-4022.
21. Perfetti R, Hui H, Chamie K et al. Pancreatic beta-cells expressing the Arg64 variant of the beta (3) -adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol 2001: 27 (2): 133-144.
22. Esterbauer H, Oberkofler H, Liu YM et al. Uncoupling protein-1 mRNA expression in obese human subjects: the role of sequence variations at the uncoupling protein-1 gene locus. J Lipid Res 1998: 39 (4): 834-844.